Smoking cessation after cancer diagnosis is linked to improved overall survival even for advanced cancers, according to a recent study.

A prespecified analysis of the SURPASS-CVOT trial assessed the efficacy and safety of tirzepatide compared with dulaglutide on kidney outcomes in patients with very high-risk CKD and type 2 diabetes.

Topline data were announced from a phase 3 study evaluating obinutuzumab in patients between 2 and 25 years of age with idiopathic nephrotic syndrome.

Coverage of the American Society of Nephrology Kidney Week annual meeting.

Given the success of atacicept in phase 2 trials, investigators tested the dual inhibitor of BAFF and APRIL in patients with IgA nephropathy in the phase 3 ORIGIN trial.

Longer-term exposure to testosterone therapy was associated with an increased risk for major adverse cardiovascular events among men.

Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

Findings showed a higher percentage of participants on obinutuzumab achieved a minimum 4-point improvement in SRI-4 at 52 weeks vs standard therapy. Topline data were announced from a phase 3 trial ...

The VALOR trial was expected to support a broader indication and include non-dialysis dependent chronic kidney disease patients. Akebia Therapeutics has decided not to initiate a clinical trial ...

Any aspirin use linked to lower hazards of MI, ischemic stroke, with greater benefit in high-frequency use group.

Study reveals 5.05 percent of individuals carry pathogenic/likely pathogenic variants in in large, unselected U.S. population.